Author's posts
Ascension splits job of president and CEO, Patricia Maryland departing
Ascension combined its “solutions” and “healthcare” divisions as the largest Catholic health system in the country looks to flatten the organization and move more quickly.
Loyola, Palos hospital systems to merge
Independent Palos Health has signed a nonbinding letter of intent to join Loyola Medicine, a not-for-profit three-hospital system owned by Catholic giant Trinity Health.
Data Points: Competition holds generic-drug prices at bay
Availability of generic drugs can impact prescription prices dramatically, but supply challenges and questions about profitability may hinder those savings.
Week Ahead: Congressional advisory panel takes up DSH allotments
The Medicaid and CHIP Payment and Access Commission is slated to meet to review recommendations on disproportionate-share hospital allotments, upper payment limit compliance, measuring program integrity and more.
Q&A: Sanford Health CEO Krabbenhoft discusses growth, acquisition of Good Samaritan
Sanford Health CEO Kelby Krabbenhoft is aiming for growth outside of the organization’s core hospital portfolio.
Are GPOs, PBMs part of the drug cost problem or the solution?
The middlemen of group purchasing organizations and pharmacy benefit managers remain a central part of the drug pricing and shortage debate.
Health systems fire up business incubators
Hospitals and health systems are launching their own incubators and partnering with existing organizations to gain access to entrepreneurs’ innovative ideas.
Commentary: Hospital-insurer collaborations can reduce readmissions, cut costs
Provider-payer collaborations, through aligned incentives and leveraging a wealth of data, can achieve better care outcomes at a lower cost.
New chairs of House committees set sights on drug prices
This week the House committee chairs finalized their subcommittees and figured out who will be leading the healthcare policy charge in the lower chamber for the 116th Congress.
CMS, Yale New Haven Health on hot seat over design of quality measures
The CMS’ long-standing hospital readmissions penalty program has taken quite a beating recently from members of the research community over problems with its underlying measures.
